đź’¨ Abstract
Lupin Limited, an Indian pharmaceutical company, has set a new record by onboarding 67,802 diabetes patients across 1,336 clinics for one of India's largest single Real-World Evidence (RWE) studies. The study, aimed at capturing real-world data, will significantly contribute to simplifying diabetes management in India.
Courtesy: theprint.in
Summarized by Einstein Beta 🤖
Suggested
Tommy Hilfiger lands in Mumbai: A stylish in-store talk and star-studded Bollywood dinner to celebrate fashion, culture & creativity
Deliure Unveils a Mango-Infused Menu to Sweeten Your Summer
Full metal jacket vs banned hollow-point bone tail—the bullet battle behind CRPF’s fresh trials
Ultima Markets Plants First Roots for Ultima Impact Foundation Through Regional Reforestation Efforts
India and CSK all-rounder Shivam Dube announces Rs 70,000 for 10 budding athletes
Baisakhi Di Raat Punjabi Icon Awards 2025 Celebrates Culture and Icons with Star-Studded Night in Mumbai
12 tourists injured in terror attack in J-K's Pahalgam
Pak PM Shehbaz leaves for Turkiye on two-day visit
Centrum Launches Centrum Recharge Energy Drink Mix with Brand Ambassador Anushka Sharma
India finish third in Peru World Cup, NRAI pleased with young shooters' performance
Powered by MessengerX.io